Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CellaVision AB

Market Cap 3.26B 341M 297M 275M 257M 482M 32.14B 486M 1.26B 15.81B 1.28B 1.25B 55.37B P/E 2026 *
22.5x
P/E 2027 * 18.7x
Enterprise Value 3.04B 318M 277M 256M 240M 450M 29.99B 453M 1.18B 14.75B 1.19B 1.17B 51.67B EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.48x
Free-Float
83.08%
Yield 2026 *
2.01%
Yield 2027 * 2.25%
1 day-3.12%
1 week+4.11%
Current month+13.43%
1 month+11.40%
3 months-9.52%
6 months-12.20%
Current year-12.98%
1 week 136.2
Extreme 136.2
154.4
1 month 118.4
Extreme 118.4
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
194
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 53.25
Extreme 53.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
06-11Buy 760 0.0032%
06-08Buy

Founder

33,000 0.1384%
06-08Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.12%+4.11%-26.69%-25.41% 341M
-1.89%-7.55%+1.67%-40.08% 15.48B
-2.00%-5.85%+25.78%+48.91% 1.57B
+0.19%+0.84%-28.35%+19.81% 1.12B
+4.11%-2.98%-51.75%-84.40% 932M
+5.56%+6.44%-16.36%-51.84% 678M
+0.58%-1.38%-40.36%-58.31% 554M
+3.24%-4.53%+37.29%-54.10% 444M
-1.26%-1.88%-53.89%-62.94% 382M
+3.15%+7.66%+11.04%+4.36% 335M
Average +0.86%-0.66%-14.16%-30.40% 2.18B
Weighted average by Cap. -1.07%-4.46%-2.58%-33.11%

Financials

2026 *2027 *
Net sales 772M 80.59M 70.2M 64.97M 60.85M 114M 7.6B 115M 299M 3.74B 302M 296M 13.09B 862M 90.08M 78.46M 72.62M 68.01M 127M 8.5B 128M 334M 4.18B 338M 331M 14.63B
Net income 145M 15.14M 13.18M 12.2M 11.43M 21.41M 1.43B 21.57M 56.11M 702M 56.82M 55.6M 2.46B 174M 18.19M 15.84M 14.66M 13.73M 25.72M 1.72B 25.92M 67.41M 844M 68.26M 66.8M 2.95B
Net Debt -218M -22.79M -19.85M -18.37M -17.21M -32.24M -2.15B -32.48M -84.48M -1.06B -85.55M -83.71M -3.7B -266M -27.78M -24.19M -22.39M -20.97M -39.28M -2.62B -39.58M -103M -1.29B -104M -102M -4.51B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-06-18 136.80 kr -3.12% 55,672
26-06-17 141.20 kr -1.67% 70,172
26-06-16 143.60 kr -2.18% 138,201
26-06-15 146.80 kr +6.22% 297,418
26-06-12 138.20 kr +5.18% 61,122
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
136.80SEK
Average target price
179.00SEK
Spread / Average Target
+30.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!